Home > Insider Trading > Filing (0001209191-11-018288)

Filing Details

Accession Number:: 0001209191-11-018288
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-16 11:29:53
Reporting Period:: 2011-03-14

Filing Date:: 2011-03-16
Accepted Time:: 2011-03-16 11:29:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1049210	Verenium Corp	VRNM	Industrial Organic Chemicals (2860)	223297375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1013473	H James Cavanaugh	44 Nassau Street Princeton NJ 08542		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-03-14	15,000	$3.16	15,000	No	4	P	Direct
Common Stock	Acquisiton	2011-03-15	9,800	$3.21	24,800	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.00-$3.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.17-$3.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.
The Reporting Person previously reported and disclaimed beneficial ownership of shares of the Issuer's Common Stock which were held by HealthCare Ventures III, L.P. (HCVIII), HealthCare Ventures IV, L.P. (HCVIV), HealthCare Ventures V, L.P. (HCVV) and HealthCare Ventures VI, L.P. (HCVVI). The Reporting Person is a General Partner of HealthCare Partners III, L.P., HealthCare Partners IV, L.P., HealthCare Partners V, L.P. and HealthCare Partners VI, L.P., the General Partners of HCVIII, HCVIV, HCVV and HCVVI, respectively. On March 11, 2011, the shares of the Issuer's Common Stock held by each of HCVIII, HCVIV, HCVV and HCVVI were distributed by each such entity to its respective limited partners. The Reporting Person did not receive any shares of the Issuer's Common Stock as a result of these distributions.